"Neoplasm Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Descriptor ID |
D009363
|
MeSH Number(s) |
D12.776.624
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Proteins".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Proteins".
This graph shows the total number of publications written about "Neoplasm Proteins" by people in this website by year, and whether "Neoplasm Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2000 | 1 | 2 | 3 |
2001 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2003 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 2 | 1 | 3 |
2007 | 1 | 4 | 5 |
2008 | 3 | 2 | 5 |
2009 | 4 | 1 | 5 |
2011 | 4 | 2 | 6 |
2012 | 2 | 1 | 3 |
2013 | 6 | 0 | 6 |
2014 | 8 | 0 | 8 |
2015 | 1 | 3 | 4 |
2016 | 3 | 0 | 3 |
2017 | 1 | 0 | 1 |
2018 | 3 | 2 | 5 |
2019 | 7 | 2 | 9 |
2020 | 1 | 2 | 3 |
2021 | 2 | 0 | 2 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Proteins" by people in Profiles.
-
LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis. Cancer Res. 2023 06 02; 83(11):1759-1761.
-
NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. Curr Oncol. 2021 11 07; 28(6):4485-4503.
-
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling. BMC Neurol. 2021 Jun 23; 21(1):231.
-
Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix. Appl Immunohistochem Mol Morphol. 2021 04 01; 29(4):299-304.
-
S100P as a marker for poor survival and advanced stage in gallbladder carcinoma. Ann Diagn Pathol. 2021 Jun; 52:151736.
-
Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors. J Cutan Pathol. 2021 Sep; 48(9):1139-1149.
-
Novel compound heterozygous variants in the NBAS gene in a child with osteogenesis imperfecta and recurrent acute liver failure. BMJ Case Rep. 2021 Feb 04; 14(2).
-
miR614 Expression Enhances Breast Cancer Cell Motility. Int J Mol Sci. 2020 Dec 24; 22(1).
-
How does fascin promote cancer metastasis? FEBS J. 2021 03; 288(5):1434-1446.
-
?Np63-Regulated Epithelial-to-Mesenchymal Transition State Heterogeneity Confers a Leader-Follower Relationship That Drives Collective Invasion. Cancer Res. 2020 09 15; 80(18):3933-3944.